AAPL282.45-1.33 (-0.47%) ▼|ABBV255.01+1.66 (+0.66%) ▲|ABT94.36+0.24 (+0.25%) ▲|ACN126.51-2.47 (-1.92%) ▼|ADBE205.77+3.04 (+1.50%) ▲|AMAT696.79+69.95 (+11.16%) ▲|AMD523.43+1.85 (+0.35%) ▲|AMGN359.60+1.27 (+0.35%) ▲|AMT169.37-6.22 (-3.54%) ▼|AMZN241.47+8.78 (+3.77%) ▲|AVGO370.48+5.46 (+1.50%) ▲|AXP340.57+0.21 (+0.06%) ▲|BA214.78-2.48 (-1.14%) ▼|BAC58.14+0.26 (+0.44%) ▲|BKNG184.63+3.17 (+1.74%) ▲|BLK949.75-14.96 (-1.55%) ▼|BMY57.68+0.16 (+0.27%) ▲|BNY144.77+1.21 (+0.84%) ▲|BRK-B497.68-0.98 (-0.20%) ▼|C142.97+1.21 (+0.85%) ▲|CAT1,019.18+21.71 (+2.18%) ▲|CL91.52-0.55 (-0.60%) ▼|CMCSA24.78+1.61 (+6.93%) ▲|COF202.53-1.47 (-0.72%) ▼|COP104.59-1.37 (-1.29%) ▼|COST954.12+1.58 (+0.17%) ▲|CRM159.10+0.73 (+0.46%) ▲|CSCO117.49+3.72 (+3.27%) ▲|CVS104.22-0.12 (-0.12%) ▼|CVX168.87-2.19 (-1.28%) ▼|DE614.43+1.19 (+0.19%) ▲|DHR193.13-3.07 (-1.56%) ▼|DIS99.10+0.31 (+0.31%) ▲|DUK128.02-0.39 (-0.30%) ▼|EMR142.25-1.24 (-0.86%) ▼|FDX323.15+4.62 (+1.45%) ▲|GD350.29+3.58 (+1.03%) ▲|GE373.97+4.97 (+1.35%) ▲|GEV1,085.90+40.73 (+3.90%) ▲|GILD126.13-1.75 (-1.37%) ▼|GM77.57-0.53 (-0.68%) ▼|GOOG349.67+14.98 (+4.47%) ▲|GOOGL351.62+14.23 (+4.22%) ▲|GS1,022.97+3.36 (+0.33%) ▲|HD347.86-1.00 (-0.29%) ▼|HON237.93-5.49 (-2.25%) ▼|IBM274.26+2.63 (+0.97%) ▲|INTC125.84-2.48 (-1.93%) ▼|INTU268.35+0.63 (+0.23%) ▲|ISRG405.81+1.54 (+0.38%) ▲|JNJ255.38+0.72 (+0.28%) ▲|JPM331.47+2.42 (+0.74%) ▲|KO82.91+0.28 (+0.34%) ▲|LIN508.81-10.81 (-2.08%) ▼|LLY1,210.75+2.63 (+0.22%) ▲|LMT504.69-2.71 (-0.53%) ▼|LOW220.25-2.23 (-1.00%) ▼|LRCX409.96+30.87 (+8.14%) ▲|MA510.18+11.16 (+2.24%) ▲|MCD266.65-3.11 (-1.15%) ▼|MDLZ59.88-0.91 (-1.50%) ▼|MDT81.46+0.48 (+0.59%) ▲|META564.60+14.35 (+2.61%) ▲|MMM163.85-0.17 (-0.10%) ▼|MO73.38-0.41 (-0.56%) ▼|MRK128.99+0.33 (+0.25%) ▲|MS213.25+1.22 (+0.58%) ▲|MSFT371.38-1.59 (-0.43%) ▼|MU1,093.91-38.42 (-3.39%) ▼|NEE87.54-1.03 (-1.16%) ▼|NFLX75.19+1.38 (+1.87%) ▲|NKE41.23+0.48 (+1.17%) ▲|NOW100.79+2.45 (+2.49%) ▲|NVDA193.91+1.38 (+0.72%) ▲|ORCL149.04+0.51 (+0.34%) ▲|PEP139.07-2.32 (-1.64%) ▼|PFE24.17-0.12 (-0.49%) ▼|PG147.47-1.55 (-1.04%) ▼|PLTR115.77+2.84 (+2.51%) ▲|PM180.45-0.32 (-0.18%) ▼|QCOM191.79+2.40 (+1.27%) ▲|RTX188.03+0.04 (+0.02%) ▲|SBUX103.23-1.37 (-1.31%) ▼|SCHW90.99+0.32 (+0.35%) ▲|SO96.86-0.31 (-0.31%) ▼|SPG225.53-1.36 (-0.60%) ▼|T21.52-1.21 (-5.30%) ▼|TMO503.37-9.67 (-1.88%) ▼|TMUS174.00-8.68 (-4.75%) ▼|TSLA399.97+20.26 (+5.34%) ▲|TXN286.92+1.50 (+0.52%) ▲|UBER75.58-0.62 (-0.81%) ▼|UNH418.00-9.89 (-2.31%) ▼|UNP271.49+3.14 (+1.17%) ▲|UPS107.24-0.91 (-0.84%) ▼|USB61.48+0.57 (+0.93%) ▲|V341.64+5.41 (+1.61%) ▲|VZ43.30-3.25 (-6.97%) ▼|WFC84.27+0.41 (+0.49%) ▲|WMT114.68-1.01 (-0.87%) ▼|XOM135.76-0.78 (-0.57%) ▼|AAPL282.45-1.33 (-0.47%) ▼|ABBV255.01+1.66 (+0.66%) ▲|ABT94.36+0.24 (+0.25%) ▲|ACN126.51-2.47 (-1.92%) ▼|ADBE205.77+3.04 (+1.50%) ▲|AMAT696.79+69.95 (+11.16%) ▲|AMD523.43+1.85 (+0.35%) ▲|AMGN359.60+1.27 (+0.35%) ▲|AMT169.37-6.22 (-3.54%) ▼|AMZN241.47+8.78 (+3.77%) ▲|AVGO370.48+5.46 (+1.50%) ▲|AXP340.57+0.21 (+0.06%) ▲|BA214.78-2.48 (-1.14%) ▼|BAC58.14+0.26 (+0.44%) ▲|BKNG184.63+3.17 (+1.74%) ▲|BLK949.75-14.96 (-1.55%) ▼|BMY57.68+0.16 (+0.27%) ▲|BNY144.77+1.21 (+0.84%) ▲|BRK-B497.68-0.98 (-0.20%) ▼|C142.97+1.21 (+0.85%) ▲|CAT1,019.18+21.71 (+2.18%) ▲|CL91.52-0.55 (-0.60%) ▼|CMCSA24.78+1.61 (+6.93%) ▲|COF202.53-1.47 (-0.72%) ▼|COP104.59-1.37 (-1.29%) ▼|COST954.12+1.58 (+0.17%) ▲|CRM159.10+0.73 (+0.46%) ▲|CSCO117.49+3.72 (+3.27%) ▲|CVS104.22-0.12 (-0.12%) ▼|CVX168.87-2.19 (-1.28%) ▼|DE614.43+1.19 (+0.19%) ▲|DHR193.13-3.07 (-1.56%) ▼|DIS99.10+0.31 (+0.31%) ▲|DUK128.02-0.39 (-0.30%) ▼|EMR142.25-1.24 (-0.86%) ▼|FDX323.15+4.62 (+1.45%) ▲|GD350.29+3.58 (+1.03%) ▲|GE373.97+4.97 (+1.35%) ▲|GEV1,085.90+40.73 (+3.90%) ▲|GILD126.13-1.75 (-1.37%) ▼|GM77.57-0.53 (-0.68%) ▼|GOOG349.67+14.98 (+4.47%) ▲|GOOGL351.62+14.23 (+4.22%) ▲|GS1,022.97+3.36 (+0.33%) ▲|HD347.86-1.00 (-0.29%) ▼|HON237.93-5.49 (-2.25%) ▼|IBM274.26+2.63 (+0.97%) ▲|INTC125.84-2.48 (-1.93%) ▼|INTU268.35+0.63 (+0.23%) ▲|ISRG405.81+1.54 (+0.38%) ▲|JNJ255.38+0.72 (+0.28%) ▲|JPM331.47+2.42 (+0.74%) ▲|KO82.91+0.28 (+0.34%) ▲|LIN508.81-10.81 (-2.08%) ▼|LLY1,210.75+2.63 (+0.22%) ▲|LMT504.69-2.71 (-0.53%) ▼|LOW220.25-2.23 (-1.00%) ▼|LRCX409.96+30.87 (+8.14%) ▲|MA510.18+11.16 (+2.24%) ▲|MCD266.65-3.11 (-1.15%) ▼|MDLZ59.88-0.91 (-1.50%) ▼|MDT81.46+0.48 (+0.59%) ▲|META564.60+14.35 (+2.61%) ▲|MMM163.85-0.17 (-0.10%) ▼|MO73.38-0.41 (-0.56%) ▼|MRK128.99+0.33 (+0.25%) ▲|MS213.25+1.22 (+0.58%) ▲|MSFT371.38-1.59 (-0.43%) ▼|MU1,093.91-38.42 (-3.39%) ▼|NEE87.54-1.03 (-1.16%) ▼|NFLX75.19+1.38 (+1.87%) ▲|NKE41.23+0.48 (+1.17%) ▲|NOW100.79+2.45 (+2.49%) ▲|NVDA193.91+1.38 (+0.72%) ▲|ORCL149.04+0.51 (+0.34%) ▲|PEP139.07-2.32 (-1.64%) ▼|PFE24.17-0.12 (-0.49%) ▼|PG147.47-1.55 (-1.04%) ▼|PLTR115.77+2.84 (+2.51%) ▲|PM180.45-0.32 (-0.18%) ▼|QCOM191.79+2.40 (+1.27%) ▲|RTX188.03+0.04 (+0.02%) ▲|SBUX103.23-1.37 (-1.31%) ▼|SCHW90.99+0.32 (+0.35%) ▲|SO96.86-0.31 (-0.31%) ▼|SPG225.53-1.36 (-0.60%) ▼|T21.52-1.21 (-5.30%) ▼|TMO503.37-9.67 (-1.88%) ▼|TMUS174.00-8.68 (-4.75%) ▼|TSLA399.97+20.26 (+5.34%) ▲|TXN286.92+1.50 (+0.52%) ▲|UBER75.58-0.62 (-0.81%) ▼|UNH418.00-9.89 (-2.31%) ▼|UNP271.49+3.14 (+1.17%) ▲|UPS107.24-0.91 (-0.84%) ▼|USB61.48+0.57 (+0.93%) ▲|V341.64+5.41 (+1.61%) ▲|VZ43.30-3.25 (-6.97%) ▼|WFC84.27+0.41 (+0.49%) ▲|WMT114.68-1.01 (-0.87%) ▼|XOM135.76-0.78 (-0.57%) ▼|
27.6 C
New York
Monday, June 29, 2026

Tag: patient

newssourceFORcompanyinformationcontent1releasesmarket

Leads Biolabs Lists on HKEX, Raising USD 189 Million Through Initial Public Offering

NANJING, China, July 24, 2025 /PRNewswire/ -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company") listed on the...

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

SAN JOSE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (“the Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that Larry L. Wood will join the Company as president and CEO effective September 2, 2025. Dr. Reza Zadno will retire as president, CEO, and director effective September 1, 2025.

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

Accesorios Reveals 150,000 Loyal Customers Built Through Six-Year Stealth Growth Strategy

Accesorios Ends Six-Year Stealth Operations, Reveals 150,000-Customer Base Built Through Word-of-Mouth

Dr. Joel Berley Launches 2026 Scholarship to Empower Aspiring Medical Leaders Nationwide

PLANTATION, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Dr. Joel Berley, a nationally respected oral surgeon and founder of Plantation Oral Surgery, is pleased to announce the official launch of the 2026 application cycle for the Dr. Joel Berley Scholarship for Future Doctors. This prestigious academic grant reflects Dr. Berley’s enduring mission to identify and uplift undergraduate students who are poised to become catalysts for progress in medicine.

Sugar Land Medical Weight Loss Expert, Dr. Adelola Ashaye, Launches Metabolic Wellness & Healthy Weight Program at InTouch Primary Care

Dr. Adelola Ashaye has launched Metabolic Wellness & Healthy Weight Program at InTouch Primary Care, offering a personalized, medically guided approach to sustainable weight loss...

Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit

MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs) 
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)

Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.

Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics

Omniscient and The Jacobs Institute launch Connectomics Innovation Program to advance stroke recovery and neurologic care with AI-enabled software.

Knee Replacement Surgery Market worth $16.17 billion in 2030 with 6.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025...

HealthSure 3X Launches Virtual In-Home Medical Services with Improved Access to Quality Care

NEWARK, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- HealthSure 3X, an online health solutions company headquartered in New Jersey, has introduced a fully integrated platform where patients can avail themselves of licensed healthcare professionals at home using virtual in-home medical care. This method caters to growing needs for accessible and flexible healthcare while upholding professional standards and patient safety.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers